Status:
COMPLETED
Cystic Fibrosis and Totally Implantable Vascular Access Devices
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Vaincre la Mucoviscidose
Conditions:
Cystic Fibrosis
Venous Thrombosis
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the incidence of venous thrombosis occurring on totally implantable vascular access devices in cystic fibrosis patients who need a new device (it can be the fi...
Detailed Description
The purpose of this study is to evaluate the incidence of venous thrombosis occurring on totally implantable vascular access devices in cystic fibrosis patients who need a new device (it can be the fi...
Eligibility Criteria
Inclusion
- Children or adults with cystic fibrosis (identified either by 2 abnormal sweat tests and/or two CFTR \[cystic fibrosis transmembrane conductance regulator\] mutations) who need a totally implantable vascular access device.
- Signed informed consent
Exclusion
- Refusal of participation in the study
- Patients on a waiting list for pulmonary or hepatic transplantation
- Patients who received a pulmonary or hepatic graft
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT00244270
Start Date
December 1 2005
End Date
March 1 2009
Last Update
August 29 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.